Cytoplasmic compartmentalization of SOX9 abrogates the growth arrest response of breast cancer cells that can be rescued by Trichostatin A treatment

Cancer Biology and Therapy

Volumn 11, Issue 1, 2011, Pages 71-83

  Chakravarty, Geetika ^a   Rider, Barbara ^a   Mondal, Debasis ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cell cycle; HDAC; IHC; Mammary gland; P21; RT profiler array; SOX9; TSA

Indexed keywords

HISTONE DEACETYLASE; TRANSCRIPTION FACTOR SOX9; TRICHOSTATIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER LOCALIZATION; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DATA ANALYSIS; DRUG ACETYLATION; ENZYME ACTIVITY; EPITHELIUM CELL; GROWTH DISORDER; HUMAN; HUMAN CELL; HUMAN TISSUE; MAMMARY GLAND; MEDICAL RECORD; MOUSE; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; FATTY ACIDS, UNSATURATED; FEMALE; GENE EXPRESSION; HUMANS; HYDROXAMIC ACIDS; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; MICE; PREGNANCY; SOX9 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 78751475720     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.11.1.13952     Document Type: Article

References (30)

1. Wegner M. Secrets to a healthy Sox life: lessons for melanocytes. Pigment Cell Res 2005; 18:74-85.
2. Schilham MW, Clevers H. HMG box containing transcription factors in lymphocyte differentiation. Semin Immunol 1998; 10:127-32.
3. Dailey L, Basilico C. Coevolution of HMG domains and homeodomains and the generation of transcriptional regulation by Sox/POU complexes. J Cell Physiol 2001; 186:315-28.
4. Dong C, Wilhelm D, Koopman P. Sox genes and cancer. Cytogenet Genome Res 2004; 105:442-7.
5. Chen Y, Shi L, Zhang L, Li R, Liang J, Yu W, et al. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem 2008; 283:17969-78.
6. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, WangQ, Bos PD, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451:147-52.
7. Harley VR, Clarkson MJ, Argentaro A. The molecular action and regulation of the testis-determining factors, SRY (sex-determining region on the Y chromosome) and SOX9 (SRY-related high-mobility group [HMG] box 9). Endocr Rev 2003; 24:466-87.
8. Barrionuevo F, Scherer G. SOX E genes: SOX9 and SOX8 in mammalian testis development. Int J Biochem Cell Biol 2010; 42:433-6.
9. Yang Y, Topol L, Lee H, Wu J. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development 2003; 130:1003-15.
10. Huang W, Chung UI, Kronenberg HM, de Crombrugghe B. The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci USA 2001; 98:160-5.
11. Kondoh H, Kamachi Y. SOX-partner code for cell specification: Regulatory target selection and underlying molecular mechanisms. Int J Biochem Cell Biol 2010; 42:391-9.
12. Panda DK, Miao D, Lefebvre V, Hendy GN, Goltzman D. The transcription factor SOX9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cells. J Biol Chem 2001; 276:41229-36.
13. Afonja O, Raaka BM, Huang A, Das S, Zhao X, Helmer E, et al. RAR agonists stimulate SOX9 gene expression in breast cancer cell lines: evidence for a role in retinoid-mediated growth inhibition. Oncogene 2002; 21:7850-60.
14. Akiyama H. Control of chondrogenesis by the transcription factor Sox9. Mod Rheumatol 2008; 18:213-9.
15. Jameson JL, Achermann JC, Ozisik G, Meeks JJ. Battle of the sexes: new insights into genetic pathways of gonadal development. Trans Am Clin Climatol Assoc 2003; 114:51-63.
16. Sakai D, Wakamatsu Y. [Regulatory mechanisms for neural crest formation]. Tanpakushitsu Kakusan Koso 2005; 50:684-91.
17. Seymour PA, Freude KK, Tran MN, Mayes EE, Jensen J, Kist R, et al. SOX9 is required for maintenance of the pancreatic progenitor cell pool. Proc Natl Acad Sci USA 2007; 104:1865-70.
18. Thomsen MK, Francis JC, Swain A. The role of Sox9 in prostate development. Differentiation 2008; 76:728-35.
19. Akiyama H, Chaboissier MC, Behringer RR, Rowitch DH, Schedl A, Epstein JA, et al. Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc Natl Acad Sci USA 2004; 101:6502-7.
20. Blache P, van de Wetering M, Duluc I, Domon C, Berta P, Freund JN, et al. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway and represses the CDX2 and MUC2 genes. J Cell Biol 2004; 166:37-47.
21. Chakravarty G, Moroz K, Makridakis NM, Lloyd SA, Galvez SE, Canavello PR, et al. Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer. Exp Biol Med 2010; In press.
22. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990; 50:6075-86.
23. McKinsey TA, Zhang CL, Lu J, Olson EN. Signaldependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 2000; 408:106-11.
24. Radu A, Neubauer V, Akagi T, Hanafusa H, Georgescu MM. PTEN induces cell cycle arrest by decreasing the level and nuclear localization of cyclin D1. Mol Cell Biol 2003; 23:6139-49.
25. Zhou BP, Liao Y, Xia W, Spohn B, Lee MH, Hung MC. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 2001; 3:245-52.
26. Baldwin AS Jr. The NFkappaB and IkappaB proteins:new discoveries and insights. Annu Rev Immunol 1996; 14:649-83.
27. Chakravarty G, Hadsell D, Buitrago W, Settleman J, Rosen JM. p190-B RhoGAP regulates mammary ductal morphogenesis. Mol Endocrinol 2003; 17:1054-65.
28. Chakravarty G, Santillan AA, Galer C, Adams HP, El-Naggar AK, Jasser SA, et al. Phosphorylated insulin like growth factor-I receptor expression and its clinico-pathological significance in histologic subtypes of human thyroid cancer. Exp Biol Med (Maywood) 2009; 234:372-86.
29. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 1997; 17:2336-46.
30. Wang Z, Chakravarty G, Kim S, Yazici YD, Younes MN, Jasser SA, et al. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma. Clin Cancer Res 2006; 12:4755-65.